ENTO Annual Interest Expense
$22.50 K
+$6600.00+41.51%
31 December 2023
Summary:
As of January 23, 2025, ENTO annual interest expense is $22.50 thousand, with the most recent change of +$6600.00 (+41.51%) on December 31, 2023. During the last 3 years, it has fallen by -$5.82 million (-99.61%). ENTO annual interest expense is now -99.62% below its all-time high of $5.94 million, reached on December 1, 2016.ENTO Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTO Quarterly Interest Expense
N/A
01 September 2024
Summary:
ENTO quarterly interest expense is not available.ENTO Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTO TTM Interest Expense
N/A
01 September 2024
Summary:
ENTO TTM interest expense is not available.ENTO TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENTO Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +41.5% | - | - |
3 y3 years | -99.6% | - | - |
5 y5 years | -77.9% | - | - |
ENTO Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +100.9% | ||||
5 y | 5-year | -99.6% | +100.9% | ||||
alltime | all time | -99.6% | +100.9% |
Entero Therapeutics Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2024 | - | $66.20 K(+1224.0%) | $71.20 K(+237.4%) |
Dec 2023 | $22.50 K(+41.5%) | - | - |
June 2023 | - | $5000.00(-44.4%) | $21.10 K(+9.3%) |
Mar 2023 | - | $9000.00(+45.2%) | $19.30 K(+21.4%) |
Dec 2022 | $15.90 K(+42.0%) | - | - |
Dec 2022 | - | $6200.00(+588.9%) | $15.90 K(+31.4%) |
Sept 2022 | - | $900.00(-71.9%) | $12.10 K(+1.7%) |
June 2022 | - | $3200.00(-42.9%) | $11.90 K(+1.7%) |
Mar 2022 | - | $5600.00(+133.3%) | $11.70 K(+4.5%) |
Dec 2021 | $11.20 K(-99.8%) | $2400.00(+242.9%) | $11.20 K(+1.8%) |
Sept 2021 | - | $700.00(-76.7%) | $11.00 K(-99.1%) |
June 2021 | - | $3000.00(-41.2%) | $1.21 M(-65.5%) |
Mar 2021 | - | $5100.00(+131.8%) | $3.51 M(-39.9%) |
Dec 2020 | $5.84 M(+1246.1%) | $2200.00(-99.8%) | $5.84 M(-2.6%) |
Sept 2020 | - | $1.20 M(-47.7%) | $5.99 M(+22.3%) |
June 2020 | - | $2.30 M(-1.3%) | $4.90 M(+80.9%) |
Mar 2020 | - | $2.33 M(+1397.3%) | $2.71 M(+524.5%) |
Dec 2019 | $433.90 K | $155.80 K(+41.1%) | $433.90 K(+55.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2019 | - | $110.40 K(-0.2%) | $279.50 K(+60.0%) |
June 2019 | - | $110.60 K(+93.7%) | $174.70 K(+58.4%) |
Mar 2019 | - | $57.10 K(+3978.6%) | $110.30 K(+8.3%) |
Dec 2018 | $101.80 K(-88.4%) | $1400.00(-75.0%) | $101.80 K(-63.6%) |
Sept 2018 | - | $5600.00(-87.9%) | $279.30 K(-59.0%) |
June 2018 | - | $46.20 K(-4.9%) | $681.80 K(-26.1%) |
Mar 2018 | - | $48.60 K(-72.8%) | $922.90 K(+5.5%) |
Dec 2017 | $875.20 K(-85.3%) | $178.90 K(-56.2%) | $875.20 K(-81.8%) |
Sept 2017 | - | $408.10 K(+42.0%) | $4.81 M(-6.2%) |
June 2017 | - | $287.30 K(>+9900.0%) | $5.12 M(-1.9%) |
Mar 2017 | - | $900.00(-100.0%) | $5.22 M(-12.0%) |
Dec 2016 | $5.94 M(+274.0%) | $4.11 M(+467.1%) | $5.94 M(+140.2%) |
Sept 2016 | - | $724.90 K(+86.8%) | $2.47 M(+9.0%) |
June 2016 | - | $388.10 K(-45.6%) | $2.27 M(+5.1%) |
Mar 2016 | - | $713.70 K(+10.7%) | $2.16 M(+35.8%) |
Dec 2015 | $1.59 M | $644.90 K(+23.9%) | $1.59 M(+68.4%) |
Sept 2015 | - | $520.60 K(+87.7%) | $942.70 K(+123.3%) |
June 2015 | - | $277.40 K(+91.7%) | $422.10 K(+191.7%) |
Mar 2015 | - | $144.70 K | $144.70 K |
FAQ
- What is Entero Therapeutics annual interest expense?
- What is the all time high annual interest expense for Entero Therapeutics?
- What is Entero Therapeutics annual interest expense year-on-year change?
- What is the all time high quarterly interest expense for Entero Therapeutics?
- What is the all time high TTM interest expense for Entero Therapeutics?
What is Entero Therapeutics annual interest expense?
The current annual interest expense of ENTO is $22.50 K
What is the all time high annual interest expense for Entero Therapeutics?
Entero Therapeutics all-time high annual interest expense is $5.94 M
What is Entero Therapeutics annual interest expense year-on-year change?
Over the past year, ENTO annual interest expense has changed by +$6600.00 (+41.51%)
What is the all time high quarterly interest expense for Entero Therapeutics?
Entero Therapeutics all-time high quarterly interest expense is $4.11 M
What is the all time high TTM interest expense for Entero Therapeutics?
Entero Therapeutics all-time high TTM interest expense is $5.99 M